Clinical Study of a New Pneumococcal Vaccine in Adults 60 through 64 Years of Age
A Phase 2, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age
Category & Conditions: Vaccine-related Conditions
Medicine: PF-06482077
ClinicalTrials.gov Identifier (NCT): NCT03313037
Protocol ID: B7471002
PrintDownloadOpen Plain Language Summary Result: Click here